This segment is the core of Toho Holdings' business, focusing on the wholesale distribution of a wide range of pharmaceutical products, including prescription drugs, over-the-counter (OTC) medications, reagents, and medical devices. The company utilizes a robust logistics network to ensure timely and efficient delivery to pharmacies, hospitals, and other healthcare providers across Japan. Research and development activities in this segment are focused on optimizing supply chain management, improving inventory control systems, and leveraging data analytics to predict demand and enhance distribution efficiency. The segment's market positioning is strong due to its extensive distribution network and established relationships with healthcare providers. Future opportunities include expanding into new therapeutic areas and enhancing its digital platforms for order management and customer support. The segment is subject to regulatory compliance with Japanese pharmaceutical laws and guidelines.

Toho Holdings operates a network of dispensing pharmacies, providing patients with access to prescribed medications and professional pharmaceutical services. This segment focuses on ensuring accurate dispensing, patient counseling, and medication management. The company invests in technologies such as automated dispensing systems and electronic health records to improve efficiency and patient safety. The therapeutic areas covered include a broad spectrum of conditions, reflecting the range of medications prescribed in Japan. Patient impact is significant, as the pharmacies provide a critical link between physicians and patients, ensuring proper medication adherence and addressing any concerns. Market positioning is competitive, with a focus on providing high-quality pharmaceutical care and convenient access to medications. Future opportunities include expanding the pharmacy network, offering specialized pharmacy services, and integrating telemedicine platforms. Regulatory compliance with pharmacy practice laws is essential.

This segment focuses on developing and providing IT solutions to support healthcare providers. This includes customer support systems, such as ENIF (an information terminal for pharmaceutical ordering), ENI-Pharmacy (a support system for the separation of dispensing and prescribing functions), and appointment systems like LXMATE HeLios and SELENE. The company also offers inventory control systems (ENIFwin) and electronic medication history recording systems (ENIFvoice SP/SP + A/Core). Research and development activities are focused on enhancing the functionality and user-friendliness of these systems, as well as integrating them with other healthcare platforms. The segment's market positioning is strong due to its focus on providing innovative solutions that improve efficiency and patient care. Future opportunities include expanding the range of IT solutions offered, integrating AI and machine learning, and expanding into new markets. Regulatory compliance with data privacy and security regulations is crucial.

Toho Holdings engages in the manufacturing and sale of generic drugs, contributing to the availability of affordable medications in Japan. This segment focuses on the development, production, and commercialization of generic pharmaceuticals, ensuring quality and efficacy. Research and development activities include formulation development, bioequivalence studies, and process optimization. The therapeutic areas covered are broad, encompassing a wide range of conditions for which generic alternatives are available. Patient impact is significant, as generic drugs provide cost-effective treatment options. Market positioning is competitive, with a focus on providing high-quality, affordable generic medications. Future opportunities include expanding the generic drug portfolio, entering new therapeutic areas, and leveraging advanced manufacturing technologies. Regulatory compliance with pharmaceutical manufacturing standards and drug approval processes is essential.